ANNOVIS BIO INC. COMMON STOCK
5.2700
27-12月-24 16:30:00
15 分の遅延
株式
+0.1100
+2.13%
本日の幅
5.0300 - 5.3400
ISIN
N/A
ソース
NYSE
-
Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients
11 6 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Announces New Publication in a Peer-Reviewed Journal
21 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results
13 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
09 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
06 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
29 4 2024 10:10:00 提供 Nasdaq GlobeNewswire
-
02 4 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
01 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
20 3 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024
27 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
14 2 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
30 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data Announcement
24 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio to Participate in the 139th Yale CEO Summit
11 12 2023 13:00:00 提供 Nasdaq GlobeNewswire
-
05 12 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Appoints Andrew Walsh as Vice President Finance
01 12 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
27 11 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate Update
08 11 2023 17:00:00 提供 Nasdaq GlobeNewswire
-
12 10 2023 08:02:38 提供 Nasdaq GlobeNewswire
-
Annovis Bio Announces First Quarter 2023 Financial Results and Provides Corporate Update
11 5 2023 07:00:01 提供 Nasdaq GlobeNewswire